|4Dec 10, 4:10 PM ET

O'Loughlin Steve 4

4 · Actinium Pharmaceuticals, Inc. · Filed Dec 10, 2018

Insider Transaction Report

Form 4
Period: 2018-12-10
O'Loughlin Steve
Chief Financial Officer
Transactions
  • Purchase

    Common Stock

    2018-12-10$0.43/sh+10,000$4,35035,500 total

Documents

1 file
  • 4
    ownership.xmlPrimary